Abstract
The study investigated the immunity and antioxidant potential of paeonol by employing a hepatocellular carcinoma (HCC) rat model. Three doses of paeonol (20, 40, 60 mg/kg b.w. orally) were administrated to diethylnitrosamine (DEN)-induced HCC rats. Results showed that paeonol significantly reduced the serum AST, ALT, ALP, GGT, AFU and liver MDA levels, increased serum WBC, TP, ALB, A/G, TNF-α and IFN-γ and liver antioxidant enzymes activities (SOD, CAT, GSH-Px, GR) in HCC rats. Altogether, these results suggest that the paeonol could effectively decrease oxidative injury and improve immunity function in HCC rats.
MeSH terms
-
Acetophenones / administration & dosage
-
Acetophenones / pharmacology*
-
Animals
-
Antioxidants / administration & dosage
-
Antioxidants / pharmacology*
-
CD4-CD8 Ratio
-
Cytokines / metabolism
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / pharmacology*
-
Liver / drug effects
-
Liver / metabolism
-
Liver Function Tests
-
Liver Neoplasms, Experimental / drug therapy*
-
Liver Neoplasms, Experimental / immunology
-
Liver Neoplasms, Experimental / metabolism
-
Lymphocyte Count
-
Rats
-
Rats, Wistar
-
Spleen / drug effects
-
Spleen / immunology
Substances
-
Acetophenones
-
Antioxidants
-
Cytokines
-
Immunologic Factors
-
paeonol